Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis

被引:117
作者
Kikuchi, T
Yamada, H
Shimmei, M
机构
[1] Department Orthopaedic Surgery, National Defense Medical College, Tokorozawa, Saitama 359
关键词
hyaluronan; osteoarthritis; animal model; cartilage;
D O I
10.1016/S1063-4584(05)80319-X
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
The effects of high molecular weight hyaluronan (HA) on cartilage degeneration were investigated in a partial menisectomy model of osteoarthritis (OA) in the rabbit knee. This study compared HA80 (0.8 x 10(6) Da, 1%), HA190 (1.9 x 10(6) Da, 0.01-1%) and saline. HA (0.1 ml/kg) or saline were injected intra-articularly twice a week immediately after surgery. Degenerative changes in femoral and tibial cartilages were graded histopathologically 2 and 4 weeks after surgery. Two weeks after surgery, HA190, only when used at a 1% concentration, resulted in a dramatic inhibition of cartilage degeneration in both the femoral condyle and the tibial plateau (P < 0.01). Two weeks after surgery, the protection against cartilage degeneration was significantly (P < 0.05) greater with HA190 than with HA80. Four weeks after surgery, only the femoral cartilage degeneration was significantly and similarly inhibited with HA190 (P < 0.01) and HA80 (P < 0.05). Scanning electron micrographs of femoral cartilage showed that cartilage degeneration was less severe with HA190 than with saline. These results might suggest that, in the rabbit model, intra-articular administration of higher molecular weight HA is more effective than lower molecular weight HA in inhibiting cartilage degeneration in early OA.
引用
收藏
页码:99 / 110
页数:12
相关论文
共 28 条
[1]  
ABATANGELO G, 1989, CLIN ORTHOP RELAT R, V241, P278
[2]   HYALURONIC ACID IN SYNOVIAL FLUID .I. MOLECULAR PARAMETERS OF HYALURONIC ACID IN NORMAL AND ARTHRITIC HUMAN FLUIDS [J].
BALAZS, EA ;
WATSON, D ;
DUFF, IF ;
ROSEMAN, S .
ARTHRITIS AND RHEUMATISM, 1967, 10 (04) :357-&
[3]  
COLOMBO C, 1983, ARTHRITIS RHEUM, V26, P857
[4]   CONCENTRATION AND MOLECULAR-WEIGHT OF SODIUM HYALURONATE IN SYNOVIAL-FLUID FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND OTHER ARTHROPATHIES [J].
DAHL, LB ;
DAHL, IMS ;
ENGSTROMLAURENT, A ;
GRANATH, K .
ANNALS OF THE RHEUMATIC DISEASES, 1985, 44 (12) :817-822
[5]   EVIDENCE FOR METALLOPROTEINASE AND METALLOPROTEINASE INHIBITOR IMBALANCE IN HUMAN OSTEOARTHRITIC CARTILAGE [J].
DEAN, DD ;
MARTELPELLETIER, J ;
PELLETIER, JP ;
HOWELL, DS ;
WOESSNER, JF .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (02) :678-685
[6]   CLINICAL-TRIAL OF INTRA-ARTICULAR INJECTION OF SODIUM HYALURONATE IN PATIENTS WITH OSTEO-ARTHRITIS OF THE KNEE [J].
DIXON, ASJ ;
JACOBY, RK ;
BERRY, H ;
HAMILTON, EBD .
CURRENT MEDICAL RESEARCH AND OPINION, 1988, 11 (04) :205-213
[7]   EFFECT OF SL-1010 (SODIUM HYALURONATE WITH HIGH-MOLECULAR-WEIGHT) ON EXPERIMENTAL OSTEOARTHRITIS INDUCED BY INTRAARTICULARLY APPLIED PAPAIN IN RABBITS [J].
KITOH, Y ;
KATSURAMAKI, T ;
TANAKA, H ;
TANAKA, M ;
KITABAYASHI, N ;
KATAOKA, M ;
FUJIMORI, S ;
UMEMOTO, J ;
NAMBA, K .
FOLIA PHARMACOLOGICA JAPONICA, 1992, 100 (01) :67-76
[8]  
KOBAYASHI Y, 1994, BIORHEOLOGY, V31, P235
[9]  
NAMIKI O, 1982, INT J CLIN PHARM TH, V20, P501
[10]  
OKADA Y, 1992, LAB INVEST, V66, P680